These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6746112)

  • 21. Functional consequence of variation in melanoma antigen expression.
    Zehngebot LM; Alexander MA; Guerry D; Cines DB; Mitchell K; Herlyn M
    Cancer Immunol Immunother; 1983; 16(1):30-4. PubMed ID: 6605801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies.
    Brüggen J; Sorg C
    Cancer Immunol Immunother; 1983; 15(3):200-5. PubMed ID: 6555061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma cell lysis by human CTL clones: differential involvement of T3, T8 and HLA antigens.
    Fossati G; Anichini A; Parmiani G
    Int J Cancer; 1987 Jun; 39(6):689-94. PubMed ID: 3108167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
    Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
    Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
    Carrel S; Schreyer M; Schmidt-Kessen A; Mach JP
    Hybridoma; 1982; 1(4):387-97. PubMed ID: 6208135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
    Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
    J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
    Anichini A; Maccalli C; Mortarini R; Salvi S; Mazzocchi A; Squarcina P; Herlyn M; Parmiani G
    J Exp Med; 1993 Apr; 177(4):989-98. PubMed ID: 8459226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies which react with the T cell receptor gamma/delta recognize different subsets of CD3+WT31- T lymphocytes.
    Ferrini S; Prigione I; Bottino C; Ciccone E; Tambussi G; Mammoliti S; Moretta L; Moretta A
    Eur J Immunol; 1989 Jan; 19(1):57-61. PubMed ID: 2784109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
    Morgan AC; McIntyre RF
    Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity.
    Jongeneel CV; Quackenbush EJ; Ronco P; Verroust P; Carrel S; Letarte M
    J Clin Invest; 1989 Feb; 83(2):713-7. PubMed ID: 2521492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
    Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
    Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
    Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
    Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
    Dippold WG; Lloyd KO; Li LT; Ikeda H; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6114-8. PubMed ID: 6934537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies.
    Mitchell KF; Fuhrer JP; Steplewski Z; Koprowski H
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7287-91. PubMed ID: 6938976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro differentiation of human melanoma cells analyzed with monoclonal antibodies.
    Ziegler-Heitbrock HW; Munker R; Johnson J; Petersmann I; Schmoeckel C; Riethmüller G
    Cancer Res; 1985 Mar; 45(3):1344-50. PubMed ID: 3971378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human melanoma-associated antigens: analysis of antigenic heterogeneity by molecular, serologic and flow-cytometric approaches.
    Morgan AC; Woodhouse C; Bartholemew R; Schroff R
    Mol Immunol; 1986 Feb; 23(2):193-200. PubMed ID: 2422545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation.
    Sugimoto T; Sawada T; Negoro S; Kidowaki T; Morioka H; Matsumura T; Kemshead JT; Seeger RC
    Cancer Res; 1985 Jan; 45(1):358-64. PubMed ID: 2981159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
    Knuth A; Wölfel T; Klehmann E; Boon T; Meyer zum Büschenfelde KH
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2804-8. PubMed ID: 2784858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
    Alexander MA; Bennicelli J; Guerry D
    J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.